Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 2,821.45
-58.20 (-2.02%)
At close: Mar 27, 2026
Ajanta Pharma Revenue
Ajanta Pharma had revenue of 13.75B INR in the quarter ending December 31, 2025, with 19.95% growth. This brings the company's revenue in the last twelve months to 52.02B, up 14.78% year-over-year. In the fiscal year ending March 31, 2025, Ajanta Pharma had annual revenue of 46.48B with 10.44% growth.
Revenue (ttm)
52.02B
Revenue Growth
+14.78%
P/S Ratio
6.74
Revenue / Employee
5.40M
Employees
9,628
Market Cap
350.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 46.48B | 4.39B | 10.44% |
| Mar 31, 2024 | 42.09B | 4.66B | 12.45% |
| Mar 31, 2023 | 37.43B | 4.02B | 12.02% |
| Mar 31, 2022 | 33.41B | 4.51B | 15.62% |
| Mar 31, 2021 | 28.90B | 3.02B | 11.66% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 345.83B |
| Lupin | 261.51B |
| Jubilant Pharmova | 79.18B |
| Abbott India | 68.24B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 38.01B |
| AstraZeneca Pharma India | 21.77B |
Ajanta Pharma News
- 6 days ago - Pharma sector stocks today, March 23: Alembic Pharma down 2.24%, Ajanta Pharma falls 1.85%, Glenmark Pharma falls 1.98% - Business Upturn
- 12 days ago - Pharma sector stocks today, March 17: Emcure Pharma surge 2.42%, Ajanta Pharma up 2.14%, Strides Pharma down 2.22% - Business Upturn
- 16 days ago - Pharma sector stocks today, March 13: Laurus Labs down 2.56%, Ajanta Pharma falls 1.88%, Granules India drops 2.14% - Business Upturn
- 27 days ago - Pharma sector stocks down today, March 2: Morepen Lab falls 3.24%, Ajanta Pharma drops 2.32%, Natco Pharma down 2.26% - Business Upturn
- 7 weeks ago - Ajanta Pharma Ltd (BOM:532331) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 7 weeks ago - Q3 2026 Ajanta Pharma Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Pharma sector stocks today, Jan 30: Aurobindo Pharma jumps 3%, Ajanta Pharma up 2%, Natco Pharma rises 2% - Business Upturn
- 2 months ago - India’s Ajanta Pharma eyes Irish manufacturing base - Independent Ireland